{
    "Trade/Device Name(s)": [
        "Smart Dongle Blood Glucose Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K162382",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101509"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JQP"
    ],
    "Summary Letter Date": "February 23, 2017",
    "Summary Letter Received Date": "February 27, 2017",
    "Submission Date": "April 11, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.2100"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood (finger)"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Smart Dongle meter",
        "iPhone series (iPhone 4, 4s, 5, 5s, 6, 6 plus, 6s, 6s plus)"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose dehydrogenase biosensor",
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Mobile application"
    ],
    "Document Summary": "FDA 510(k) summary for Smart Dongle Blood Glucose Monitoring System, an electrochemical biosensor system for glucose measurement using iPhone as display.",
    "Indications for Use Summary": "Intended for self-testing of blood glucose by people with diabetes at home to monitor diabetes control effectiveness using fresh capillary whole blood from the finger; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}